Publisher Correction: Radioactive drugs emerge from the shadows to storm the market

被引：0

作者：

Elie Dolgin

机构：

[1] Somerville,

来源：

Nature Biotechnology | 2019年 / 37卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In the version of this article initially published, Betalutin was described as directing a radioisotope to CD45-expressing B cells; in fact, it directs it to CD37-expressing B cells. The error has been corrected in the HTML and PDF versions of the article.

引用

页码：193 / 193